Burke William P. Mr.'s Form 4 filing
Axogen, Inc.AXGN · filed Oct 31, 2025
- Accession no.
- 0000805928-25-000132
- Filed
- Oct 31, 2025
- Trade date
- Oct 29-30, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.25M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Burke William P. Mr.CIK 0001682069 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 29, 2025 | Common Stock | MOption exerciseAcquired | +20,436 | $6.30 | +$128,746.8 | 20,536 | Direct | |
| Oct 29, 2025 | Common Stock | SSaleDisposed | −20,436 | $19.15F1 | −$391,349.4 | 100 | Direct | |
| Oct 29, 2025 | Common Stock | MOption exerciseAcquired | +19,799 | $8.14 | +$161,163.86 | 19,899 | Direct | |
| Oct 29, 2025 | Common Stock | SSaleDisposed | −19,799 | $22.00F2 | −$435,578 | 100 | Direct | |
| Oct 30, 2025 | Common Stock | MOption exerciseAcquired | +18,248 | $7.04 | +$128,465.92 | 18,348 | Direct | |
| Oct 30, 2025 | Common Stock | SSaleDisposed | −18,248 | $23.00F2 | −$419,704 | 100 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 29, 2025 | Common Stock | MOption exerciseDisposed | −20,436 | $0.00 | $0 | 0 | Direct | |
| Oct 29, 2025 | Common Stock | MOption exerciseDisposed | −19,799 | $0.00 | $0 | 39,596 | Direct | |
| Oct 30, 2025 | Common Stock | MOption exerciseDisposed | −18,248 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.50 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F2
The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025.
Referenced by the price of 2 transactions in Table I.